Prescribing Information
\
Medication Guide
\
Important Safety Information
\
Privacy Policy
\
References
\
Site Map
Suicidality and Antidepressant Drugs
Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, teens, and young adults. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. EMSAM is not approved for use in children under 18.
Home
\
Understanding MDD (Depression)
\
About EMSAM
\
Instant Savings Program
\
Patients
\
Health Care Professionals
Blind References:
EMSAM prescribing information, Dey Pharma, L.P. May 2009.
Depression. National Institute of Mental Health Web site. Available at: http://www.nimh.nih.gov/health/publications/depression/complete-index.shtml Updated September 23, 2010. Accessed March 9, 2011.
Depression (major depression). Mayo Clinic Web site. Available at: http://www.mayoclinic.com/health/depression/DS00175. Updated February 11, 2010. Accessed March 9, 2011.
Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).
JAMA
. 2003;289:3095-3105.
Stahl SM. Essential Psychopharmacology. Neuroscientific Basis and Practical Applications. Second Edition. Cambridge University Press 2000.
Depression and Bipolar Support Alliance. The Value of DBSA Support Groups. Available at: http://www.dbsalliance.org/site/PageServer?pagename=support_supportgroups Accessed July 7, 2011.
National Suicide Prevention Hotline Web site. Available at: http://www.suicidepreventionlifeline.org/. Accessed June 30, 2011.
Preskorn SH. Why the transdermal delivery of selegiline (6 mg/24 hr) obviates the need for a dietary restriction on tyramine.
J Psychiatr Pract
. 2006;12:168-172.
Fiedorowicz JG, Swartz KL. The Role of Monoamine Oxidase Inhibitors in Current Psychiatric Practice.
J Psychiatr Pract.
2004;10(4):239-248.
Bodkin JA, Amsterdam JD. Transdermal selegiline in major depression: a double-blind, placebo-controlled, parallel-group study in outpatients.
Am J Psychiatry
. 2002;159:1869-1875.
Amsterdam JD, Bodkin JA. Selegiline transdermal system in the prevention of relapse of major depressive disorder: a 52-week, double-blind, placebo-substitution, parallel-group clinical trial.
J Clin Psychopharmacol
. 2006;26:579-586.
Rush AJ, Trivedi MH, Wisniewski SR, et al, for the STAR*D Study Team. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
N Engl J Med
. 2006;354:1231-1242.
Trivedi MH, Fava M, Wisniewski SR, et al, for the STAR*D Study Team. Medication augmentation after the failure of SSRIs for depression.
N Engl J Med
. 2006;354:1243-1252.